Artelo Biosciences Inc (ARTL) — Financial Flexibility Index
Artelo Biosciences Inc (ARTL) has a Financial Flexibility Index of -0.20x as of March 2026. Free cash flow of $-1.19 Million (operating CF $-1.19 Million minus capex $1.00) represents 0% of total liabilities ($5.85 Million). Check ARTL intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Artelo Biosciences Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Artelo Biosciences Inc across 11 annual periods. For the full cash flow conversion analysis, see Artelo Biosciences Inc (ARTL) cash flow conversion.
Annual Financial Flexibility Index for Artelo Biosciences Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Artelo Biosciences Inc. Explore Artelo Biosciences Inc (ARTL) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.09x | $-8.52 Million | $-8.52 Million | $4.07 Million | ▲ +53.9% |
| 2024 | -4.54x | $-8.35 Million | $-8.35 Million | $1.84 Million | ▲ +28.7% |
| 2023 | -6.36x | $-8.21 Million | $-8.21 Million | $1.29 Million | ▲ +18.9% |
| 2022 | -7.84x | $-8.01 Million | $-8.01 Million | $1.02 Million | ▲ +24.3% |
| 2021 | -10.36x | $-6.14 Million | $-6.14 Million | $593.00K | ▼ -82.7% |
| 2020 | -5.67x | $-2.85 Million | $-4.35 Million | $502.18K | ▼ -348.1% |
| 2019 | -1.26x | $-1.29 Million | $-2.79 Million | $1.02 Million | ▲ +58.2% |
| 2018 | -3.02x | $-1.61 Million | $-1.61 Million | $531.97K | ▲ +58.8% |
| 2017 | -7.34x | $-215.98K | $-216.82K | $29.44K | ▼ -623.1% |
| 2016 | -1.01x | $-17.64K | $-18.49K | $17.39K | ▲ +86.1% |
| 2015 | -7.28x | $-12.66K | $-13.50K | $1.74K | — |